Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...
AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tra...more...
AstraZeneca Pharma India Limited has informed the Exchange about Resignation of Director/KMP/SMPmore...
Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.more...
Please find the enclosed intimation of the Company as per the captioned subject for review.more...
AstraZeneca Pharmaceuticals ABÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Boar...more...
AstraZeneca Pharma India Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companymore...
AstraZeneca Pharma India Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regu...more...
Please find the enclosed intimation of the Company as per the captioned subject for your reference.more...
Please find the enclosed letter of the Company in relation to the captioned subject for your reference.more...
AstraZeneca Pharma India Limited has submitted to the Exchange the financial results for the period ended March 31 2026.more...
AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated May 26 2026 titled AstraZeneca Pharma India Limit...more...
The company reported standalone net profit of Rs 44.88 crore for the quarter ended March 31 2026 as compared to Rs 58.25 crore in the same period las...more...
Please find the enclosed intimation of the Company as per the captioned subject for reference.more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026